Infectious diseases fungal

Recurrent ovarian cancer Infectious disease Fungal infection, AIDS Ophthalmic disease... 

Lopez-Berestein, G. (1989). Treatment of systemic fungal infections with liposomal-amphotericin B, in Liposomes in the Therapy of Infectious Diseases and Cancer (G. Lopez-Berestein and I. J. Fidler, eds.), Alan R. Liss, New York, pp. 317-327. 

Combating infectious diseases (viral, protozoal, fungal, bacterial, helminthic) Anti-cancer agent Alleviating allergic reactions Vaccine adjuvant... 

An accumulating series of case reports has focused on the possible more frequent occurrence of opportunistic infections despite normal leukocyte counts in patients treated for rheumatoid arthritis or, less often, psoriasis (97,100,101). Various bacterial, fungal, and viral opportunistic infections have been described, with Pneumocystis jiroveci pneumonia as the most frequently reported (SEDA-21, 389) (SEDA-22, 417). Although the most severe, sometimes fatal, infectious diseases were usually observed in patients also taking glucocorticoids (SEDA-22, 417) (102,103), severe infections can also occur in occasional patients not taking concomitant glucocorticoids (SEDA-21, 389) (101,104-107). 

Fleming. R.V.. Walsh, T.J., and Anaissie. E.J. (2002) Emerging and less common fungal pathogens. Infectious Disease Clinics of North America, 16, 915-933 vi-vii. 

Public Flealth Service and the Infectious Diseases Society of America, as well as other experts in the area, do not recommend routine primary prophylaxis for OPC. The rationale includes effectiveness of therapy for acute episodes of OPC, low incidence of serious invasive fungal disease, low mortality associated with mucosal candidiasis, the potential development of resistant candidiasis, the possibility of drug interactions, and the prohibitive long-term cost of prophylaxis. For the same reasons, chronic suppressive therapy (i.e., secondary prophylaxis of recurrent OPC) is also not recommended routinely, but rather clinicians should treat each acute episode as it occurs. ... 

Infectious diseases account for one-third of all deaths worldwide. Although the last decade has yielded significant advances in the treatment of infectious diseases, new therapies for viral, fungal, bacterial and parasitic infections are needed [1],... 

Characterization 366 Bacterial Pneumonia 367 Fungal Pneumonia 367 Pneumocystis Jiroveci Pneumonia (PcP) 369 Tuberculosis 369 Viral Pneumonia 370 Non-Infectious Disease 370 Graft vs Host Disease 370 Radiation Toxicity 37J Drug Toxicity 371 Pulmonary Congestion 372 Leukemic Infiltration 372 Pulmonary Hemorrhage 372... 

---